Benefit-cost analysis of vaccination of horses as a strategy to control equine monocytic ehrlichiosis

Journal of the American Veterinary Medical Association

Volumn 208, Issue 8, 1996, Pages 1295-1299

  Atwill, Edward R ^a,b   Mohammed, Hussni O ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE CONTROL STUDY; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DECISION TREE; ECONOMICS; EHRLICHIOSIS; HORSE; HORSE DISEASE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNITED STATES; VACCINATION;

ANIMALS; CASE-CONTROL STUDIES; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DECISION TREES; EHRLICHIOSIS; HORSE DISEASES; HORSES; NEW YORK; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VACCINATION;

EID: 0030584705     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Palmer JE. Prevention of Potomac horse fever. Cornell Vet 1989;79:201-205.
2. Atwill ER, Mohammed HO. Evaluation of vaccination of horses as a strategy to control equine monocytic ehrlichiosis. J Am Vet Med Assoc 1996;208:1290-1294.
3. Ristic M, Holland CJ, Goetz TE, et al. Evaluation of a vaccine for equine monocytic ehrlichiosis, in Proceedings. Symp Potomac Horse Fever 1987;89-100.
4. Whitlock RH, Palmer JE, Meinersmann RJ, et al. Evaluation of an experimental vaccine for Potomac horse fever, in Proceedings. Symp Potomac Horse Fever 1987;61-72.
5. Sessions J, Dawson JE. Maryland field evaluation of the Potomac horse fever vaccine. Equine Pract 1988;10:7-12.
6. Atwill ER, Mohammed HO, Lopez JW, et al. Cross-sectional evaluation of environmental, host, and management factors associated with risk of seropositivity to Ehrlichia risticii in horses of New York state. Am J Vet Res 1996;57:278-285.
7. Palmer JE, Benson CE, Whitlock RH. Effect of treatment with oxytetracycline during the acute stages of experimentally induced equine ehrlichial colitis in ponies. Am J Vet Res 1992;53:2300-2304.
8. Atwill ER, Mohammed HO, Lopez JW. Evaluation of travel and use as a risk factor for seropositivity to Ehrlichia risticii in horses of New York state. Am J Vet Res 1996;57:272-277.
9. Weinstein MC, Fineberg HV, Elstein AS, et al. Clinical decision analysis. Philadelphia: WB Saunders Co, 1980.
10. Casella G, Berger RL. Probability theory. In: Statistical inference. Pacific Grove, Calif: Brooks/Cole Publishing Co, 1990.
11. Atwill ER, Mohammed HO. Reliable estimate of the annual incidence of equine monocytic ehrlichiosis in New York. Prev Vet Med 1995;23:41-51.
12. Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-235.
13. Kleinbaum DG, Kupper LL, Morgenstern H. Measures of disease frequency: incidence. In: Epidemiologic research. Principles and quantitative methods. New York: Van Nostrand Reinhold, 1982.
14. Olchowy TWJ, Ames TR, Molitor TW. Serodiagnosis of equine monocytic ehrlichiosis in selected groups of horses in Minnesota. J Am Vet Med Assoc 1990;196:1967-1970.
15. Palmer JE, Whitlock RH, Benson CE. Equine ehrlichial colitis (Potomac horse fever): recognition of the disease in Pennsylvania, New Jersey, New York, Ohio, Idaho, and Connecticut. J Am Vet Med Assoc 1986;189:197-199.